Overt immediate hemolytic transfusion reaction attributable to anti-Wra
24 mars 2020
À propos de cet article
Catégorie d'article: Case Report
Publié en ligne: 24 mars 2020
Pages: 113 - 115
DOI: https://doi.org/10.21307/immunohematology-2019-282
Mots clés
© 2008 F.N. Boctor, published by Sciendo
Wra is a low-prevalence antigen. Anti-Wra is a relatively common antibody present in approximately 1 in 100 healthy blood donors. Anti-Wra is reported to cause different degrees of hemolysis in transfusion and in HDN, ranging from benign to severe. This report describes an acute overt hemolytic transfusion reaction in a patient whose serum contained anti-Wra and who received a Wr(a+) RBC component.